Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Jun 14, 2013 · 10-Q · 45 days after period end · 0001079973-13-000401
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $258.00K | $207.00K | $128.00K |
| Net Income | -$1.53M | -$1.83M | -$1.82M |
| EPS Diluted | -$0.14 | -$0.31 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Apr 30, 2013 · filed Jun 14, 2013 · 45 d after period end
